Interstitial fluid contains higher in vitro IGF bioactivity than serum: A study utilizing the suction blister technique

Growth Hormone and IGF Research

Volumn 22, Issue 6, 2012, Pages 234-239

  Espelund, Ulrick ^a,b   Søndergaard, Klaus ^a,b   Bjerring, Peter ^c   Flyvbjerg, Allan ^a,b   Frystyk, Jan ^a,b  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b AARHUS UNIVERSITY   (Denmark)

^c Private Hospital Mølholm   (Denmark)

Author keywords

Biological assay; Extracellular fluid; Fasting; Insulin like growth factor; Insulin like growth factor binding protein; Kinase receptor activation assay

Indexed keywords

SOMATOMEDIN; SOMATOMEDIN B; SOMATOMEDIN BINDING PROTEIN; SOMATOMEDIN BINDING PROTEIN 1; SOMATOMEDIN BINDING PROTEIN 2; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN BINDING PROTEIN 4; SOMATOMEDIN BINDING PROTEIN 5; SOMATOMEDIN BINDING PROTEIN 6; SOMATOMEDIN C RECEPTOR;

ADULT; ANALYTIC METHOD; ARTICLE; CONTROLLED STUDY; DIET RESTRICTION; ENZYME DEGRADATION; FOOD INTAKE; HORMONE ACTION; HUMAN; HUMAN EXPERIMENT; IMMUNOREACTIVITY; IN VITRO STUDY; INTERSTITIAL FLUID; MALE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SUCTION BLISTER TECHNIQUE; WESTERN BLOTTING;

ADULT; ANALYSIS OF VARIANCE; BLOTTING, WESTERN; EATING; EXTRACELLULAR FLUID; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR BINDING PROTEINS; INSULIN-LIKE GROWTH FACTOR I; INSULIN-LIKE GROWTH FACTOR II; MALE; SOMATOMEDINS;

EID: 84868482151     PISSN: 10966374     EISSN: 15322238     Source Type: Journal    
DOI: 10.1016/j.ghir.2012.08.002     Document Type: Article

References (35)

1. Zapf J., Hauri C., Futo E., Hussain M., Rutishauser J., Maack C.A., Froesch E.R. Intravenously injected insulin-like growth factor (IGF) I/IGF binding protein-3 complex exerts insulin-like effects in hypophysectomized, but not in normal rats. J. Clin. Invest. 1995, 95:179-186.
2. Payet L.D., Firth S.M., Baxter R.C. The role of the acid-labile subunit in regulating insulin-like growth factor transport across human umbilical vein endothelial cell monolayers. J. Clin. Endocrinol. Metab. 2004, 89:2382-2389.
3. Xu S., Cwyfan-Hughes S.C., van der Stappen J.W., Sansom J., Burton J.L., Donnelly M., Holly J.M. Insulin-like growth factors (IGFs) and IGF-binding proteins in human skin interstitial fluid. J. Clin. Endocrinol. Metab. 1995, 80:2940-2945.
4. Lalou C., Binoux M. Evidence that limited proteolysis of insulin-like growth factor binding protein-3 (IGFBP-3) occurs in the normal state outside of the bloodstream. Regul. Pept. 1993, 48:179-188.
5. Blat C., Villaudy J., Binoux M. In vivo proteolysis of serum insulin-like growth factor (IGF) binding protein-3 results in increased availability of IGF to target cells. J. Clin. Invest. 1994, 93:2286-2290.
6. Møller A.V., Jørgensen S.P., Chen J.W., Larnkjær A., Ledet T., Flyvbjerg A., Frystyk J. Glycosaminoglycans increase levels of free and bioactive IGF-I in vitro. Eur. J. Endocrinol. 2006, 155:297-305.
7. Jeyaratnaganthan N., Grønbæk H., Holland-Fischer P., Espelund U., Chen J.W., Flyvbjerg A., Vilstrup H., Frystyk J. Ascites from patients with alcoholic liver cirrhosis contains higher IGF-I bioactivity than serum. Clin. Endocrinol. (Oxf) 2009, 72:625-632.
8. Chen J.W., Ledet T., Ørskov H., Jessen N., Lund S., Whittaker J., De Meyts P., Larsen M.B., Christiansen J.S., Frystyk J. A highly sensitive and specific assay for determination of IGF-I bioactivity in human serum. Am. J. Physiol. Endocrinol. Metab. 2003, 284:E1149-E1155.
9. Frystyk J., Ivarsen P., Skjærbæk C., Flyvbjerg A., Pedersen E.B., Ørskov H. Serum-free insulin-like growth factor I correlates with clearance in patients with chronic renal failure. Kidney Int. 1999, 56:2076-2084.
10. Kiistala U., Mustakallio K.K. In-vivo separation of epidermis by production of suction blisters. Lancet 1964, 1:1444-1445.
11. Rossing N., Worm A.M. Interstitial fluid: exchange of macromolecules between plasma and skin interstitium. Clin. Physiol. 1981, 1:275-284.
12. Vermeer B.J., Reman F.C., van Gent C.M. The determination of lipids and proteins in suction blister fluid. J. Invest. Dermatol. 1979, 73:303-305.
13. Black A.K., Greaves M.W., Hensby C.N., Plummer N.A., Eady R.A. A new method for recovery of exudates from normal and inflamed human skin. Clin. Exp. Dermatol. 1977, 2:209-216.
14. Groth S., Staberg B. Suction blisters of the skin: a compartment with physiological, interstitium-like properties. Scand. J. Clin. Lab. Invest. 1984, 44:311-316.
15. Staberg B., Groth S., Rossing N. Passage of albumin from plasma to suction skin blisters. Clin. Physiol. 1983, 3:375-380.
16. Kiistala U., Mustakallio K.K., Rorsman H. Suction blisters in the study of cellular dynamics of inflammation. Acta Derm. Venereol. 1967, 47:150-153.
17. Herfst M.J., van R.H. Suction blister fluid as a model for interstitial fluid in rats. Arch. Dermatol. Res. 1978, 263:325-334.
18. Nindl B.C., Tuckow A.P., Alemany J.A., Harman E.A., Rarick K.R., Staab J.S., Faupel M.L., Khosravi M.J. Minimally invasive sampling of transdermal body fluid for the purpose of measuring insulin-like growth factor-I during exercise training. Diabetes Technol. Ther. 2006, 8:244-252.
19. Scofield D.E., McClung H.L., McClung J.P., Kraemer W.J., Rarick K.R., Pierce J.R., Cloutier G.J., Fielding R.A., Matheny R.W., Young A.J., Nindl B.C. A novel, noninvasive transdermal fluid sampling methodology: IGF-I measurement following exercise. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2011, 300:R1326-R1332.
20. Rechler M.M. Insulin-like growth factor binding proteins. Vitam. Horm. 1993, 47:1-114.
21. Bang P., Brismar K., Rosenfeld R.G. Increased proteolysis of insulin-like growth factor-binding protein-3 (IGFBP-3) in noninsulin-dependent diabetes mellitus serum, with elevation of a 29-kilodalton (kDa) glycosylated IGFBP-3 fragment contained in the approximately 130- to 150-kDa ternary complex. J. Clin. Endocrinol. Metab. 1994, 78:1119-1127.
22. Brand-Miller J.C., Liu V., Petocz P., Baxter R.C. The glycemic index of foods influences postprandial insulin-like growth factor-binding protein responses in lean young subjects. Am. J. Clin. Nutr. 2005, 82:350-354.
23. Arafat A.M., Weickert M.O., Frystyk J., Spranger J., Schofl C., Mohlig M., Pfeiffer A.F. The role of insulin-like growth factor (IGF) binding protein-2 in the insulin-mediated decrease in IGF-I bioactivity. J. Clin. Endocrinol. Metab. 2009, 94:5093-5101.
24. Bar R.S., Boes M., Clemmons D.R., Busby W.H., Sandra A., Dake B.L., Booth B.A. Insulin differentially alters transcapillary movement of intravascular IGFBP-1, IGFBP-2 and endothelial cell IGF-binding proteins in the rat heart. Endocrinology 1990, 127:497-499.
25. Brismar K., Hilding A., Lindgren B. Regulation of IGFBP-1 in humans. Prog. Growth Factor Res. 1995, 6:449-456.
26. Frystyk J. Quantification of the GH/IGF-axis components: lessons from human studies. Domest. Anim. Endocrinol. 2011, 43:186-197.
27. Chen J.W., Nielsen M.F., Caumo A., Vilstrup H., Christiansen J.S., Frystyk J. Changes in bioactive IGF-I and IGF-binding protein-1 during an oral glucose tolerance test in patients with liver cirrhosis. Eur. J. Endocrinol. 2006, 155:285-292.
28. Frystyk J. Free insulin-like growth factors - measurements and relationships to growth hormone secretion and glucose homeostasis. Growth Horm. IGF Res. 2004, 14:337-375.
29. Berg U., Gustafsson T., Sundberg C.J., Kaijser L., Carlsson-Skwirut C., Bang P. Interstitial IGF-I in exercising skeletal muscle in women. Eur. J. Endocrinol. 2007, 157:427-435.
30. Desvigne N., Barthelemy J.C., Frere D., Gay-Montchamp J.P., Costes F. Microdialysis of insulin-like growth factor-I in human muscle. Eur. J. Appl. Physiol. 2005, 94:216-219.
31. Xu S., Savage P., Burton J.L., Sansom J., Holly J.M. Proteolysis of insulin-like growth factor-binding protein-3 by human skin keratinocytes in culture in comparison to that in skin interstitial fluid: the role and regulation of components of the plasmin system. J. Clin. Endocrinol. Metab. 1997, 82:1863-1868.
32. Gargosky S.E., Pham H.M., Wilson K.F., Liu F., Giudice L.C., Rosenfeld R.G. Measurement and characterization of insulin-like growth factor binding protein-3 in human biological fluids: discrepancies between radioimmunoassay and ligand blotting. Endocrinology 1992, 131:3051-3060.
33. Maile L.A., Xu S., Cwyfan-Hughes S.C., Fernihough J.K., Pell J.M., Holly J.M. Active and inhibitory components of the insulin-like growth factor binding protein-3 protease system in adult serum, interstitial, and synovial fluid. Endocrinology 1998, 139:4772-4781.
34. Hughes S.C., Mason H.D., Franks S., Holly J.M. The insulin-like growth factors (IGFs) in follicular fluid are predominantly bound in the ternary complex. J. Endocrinol. 1997, 155:R1-R4.
35. Hughes S.C., Xu S., Fernihough J., Hampton A., Mason H.D., Franks S., van der Stappen J., Donnelly M.J., Holly J.M. Tissue IGFBP-3 proteolysis: contrasting pathophysiology to that in the circulation. Prog. Growth Factor Res. 1995, 6:293-299.